Providing β-Lactams a Helping Hand: Targeting the Ampc β-Lactamase Induction Pathway
- 28 November 2011
- journal article
- research article
- Published by Taylor & Francis in Future Microbiology
- Vol. 6 (12) , 1415-1427
Abstract
A major cause of the clinical failure of broad-spectrum β-lactam antibiotics against Pseudomonas aeruginosa and many Enterobacteriaceae species are chromosomal mutations that lead to the hyperproduction of AmpC β-lactamase. These mutations typically affect proteins within the peptidoglycan (PG) recycling pathway, as well as proteins that are modulated by metabolic intermediates of this pathway. Blocking PG recycling and associated sensing mechanisms with small-molecule inhibitors holds promise as a strategy for overcoming AmpC-mediated resistance that results from the selection of mutations during β-lactam therapy, or from the direct acquisition of infections by AmpC-producing mutants. Here we report on the structural and functional biology of potential drug targets within the Gram-negative PG recycling pathway and the utility of blocking PG recycling as a means of attenuating AmpC-mediated resistance in P. aeruginosa.Keywords
Funding Information
- Canadian Institutes of Health Research
- The Manitoba Health Research Council
- Instituto de Salud Carlos III
- Spanish Network for Research in Infectious Diseases (REIPI RD06/0008, PS09/00033)
- Research Chair
- Canada Research Chair
This publication has 92 references indexed in Scilit:
- Challenging and emerging pathogens in cystic fibrosisPaediatric Respiratory Reviews, 2010
- Updated Functional Classification of β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance MechanismsClinical Microbiology Reviews, 2009
- The clinical consequences of antimicrobial resistanceCurrent Opinion in Microbiology, 2009
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling OpportunityChemical Reviews, 2005
- Pathophysiology and Management of Pulmonary Infections in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Lung Infections Associated with Cystic FibrosisClinical Microbiology Reviews, 2002
- ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.Proceedings of the National Academy of Sciences, 1981
- The structure of β-lactamasesPhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1980